These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30611608)

  • 1. Disordered Protein Kinase Regions in Regulation of Kinase Domain Cores.
    Gógl G; Kornev AP; Reményi A; Taylor SS
    Trends Biochem Sci; 2019 Apr; 44(4):300-311. PubMed ID: 30611608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orchestration of signaling by structural disorder in class 1 cytokine receptors.
    Seiffert P; Bugge K; Nygaard M; Haxholm GW; Martinsen JH; Pedersen MN; Arleth L; Boomsma W; Kragelund BB
    Cell Commun Signal; 2020 Aug; 18(1):132. PubMed ID: 32831102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction modules that impart specificity to disordered protein.
    Cermakova K; Hodges HC
    Trends Biochem Sci; 2023 May; 48(5):477-490. PubMed ID: 36754681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Methods to Predict Intrinsically Disordered Regions and Functional Regions in Them.
    Anbo H; Ota M; Fukuchi S
    Methods Mol Biol; 2023; 2627():231-245. PubMed ID: 36959451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic mutations of human phosphorylation sites affect protein-protein interactions.
    Rrustemi T; Meyer K; Roske Y; Uyar B; Akalin A; Imami K; Ishihama Y; Daumke O; Selbach M
    Nat Commun; 2024 Apr; 15(1):3146. PubMed ID: 38605029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome-wide analysis of human disease mutations in short linear motifs: neglected players in cancer?
    Uyar B; Weatheritt RJ; Dinkel H; Davey NE; Gibson TJ
    Mol Biosyst; 2014 Oct; 10(10):2626-42. PubMed ID: 25057855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP in Tetrapoda: Intrinsically Disordered Regions, Short Linear Motifs and their evolutionary significance.
    Viscardi LH; Tovo-Rodrigues L; Paré P; Fagundes NJR; Salzano FM; Paixão-Côrtes VR; Bau CHD; Bortolini MC
    Genet Mol Biol; 2017; 40(1):181-190. PubMed ID: 28257525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of short linear interaction motifs in SARS-CoV-2 nucleocapsid protein.
    Schuck P; Zhao H
    mBio; 2023 Nov; 14(6):e0238823. PubMed ID: 38018991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lighting up kinase contacts in situ.
    Chu G; Li YM
    Nat Chem Biol; 2024 May; 20(5):544-545. PubMed ID: 38302605
    [No Abstract]   [Full Text] [Related]  

  • 10. Measuring agonist-induced ERK MAP kinase phosphorylation for G-protein-coupled receptors.
    Kumari P; Dwivedi H; Baidya M; Shukla AK
    Methods Cell Biol; 2019; 149():141-153. PubMed ID: 30616816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuning the "violin" of protein kinases: The role of dynamics-based allostery.
    Ahuja LG; Taylor SS; Kornev AP
    IUBMB Life; 2019 Jun; 71(6):685-696. PubMed ID: 31063633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renaissance of Allostery to Disrupt Protein Kinase Interactions.
    Leroux AE; Biondi RM
    Trends Biochem Sci; 2020 Jan; 45(1):27-41. PubMed ID: 31690482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intact Transition Epitope Mapping-Force Interferences by Variable Extensions (ITEM-FIVE).
    Koy C; Röwer C; Thiesen HJ; Neamtu A; Glocker MO
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline
    Panagopoulos I; Andersen K; Stavseth V; Torkildsen S; Heim S; Tandsæther MR
    Cancer Genomics Proteomics; 2024; 21(3):272-284. PubMed ID: 38670586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on evolutionary, structural, and functional studies of receptor-like kinases in plants.
    Liu J; Li W; Wu G; Ali K
    Front Plant Sci; 2024; 15():1305599. PubMed ID: 38362444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization.
    Meng Y; Garnish SE; Davies KA; Black KA; Leis AP; Horne CR; Hildebrand JM; Hoblos H; Fitzgibbon C; Young SN; Dite T; Dagley LF; Venkat A; Kannan N; Koide A; Koide S; Glukhova A; Czabotar PE; Murphy JM
    Nat Commun; 2023 Oct; 14(1):6804. PubMed ID: 37884510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic and evolutionary insights into isoform-specific 'supercharging' in DCLK family kinases.
    Venkat A; Watterson G; Byrne DP; O'Boyle B; Shrestha S; Gravel N; Fairweather EE; Daly LA; Bunn C; Yeung W; Aggarwal I; Katiyar S; Eyers CE; Eyers PA; Kannan N
    Elife; 2023 Oct; 12():. PubMed ID: 37883155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation-Assisted Luciferase Complementation Assay Designed to Monitor Kinase Activity and Kinase-Domain-Mediated Protein-Protein Binding.
    Póti ÁL; Dénes L; Papp K; Bató C; Bánóczi Z; Reményi A; Alexa A
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the Protein Isoforms of
    Vasquez OE; Allen AM; So AK; Nguyen QH; Krause HM; Levine JD; Sokolowski MB
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereochemical engineering yields a multifunctional peptide macrocycle inhibitor of Akt2 by fine-tuning macrocycle-cell membrane interactions.
    Nag A; Mafi A; Das S; Yu MB; Alvarez-Villalonga B; Kim SK; Su Y; Goddard WA; Heath JR
    Commun Chem; 2023 May; 6(1):95. PubMed ID: 37202473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.